When COVID‑19 swept the globe, one fact stood out: the disease did not affect everyone the same way. Some people experienced only a sniffle, while others faced life‑threatening complications. This stark contrast sparked a fundamental question—why do two individuals exposed to the exact same virus react so differently?
Genes, Experiences, and the Invisible Code
The answer lies in a combination of the DNA you inherit and the life you lead. Both factors leave subtle chemical marks on your genome, known as epigenetic modifications. These marks act like switches, turning genes on or off without changing the underlying DNA sequence, and they dictate how immune cells operate.
Building a Cell‑Specific Epigenetic Reference
Scientists at the Salk Institute recently compiled a comprehensive catalog that maps these epigenetic signatures across several immune cell types. Published in Nature Genetics (January 27 2026), the database shows how inherited traits and life‑time exposures imprint distinct patterns on T cells, B cells, monocytes, and natural‑killer cells.
How Life Events Stamp the Immune System
The team examined blood from 110 volunteers representing a broad spectrum of genetic backgrounds and exposure histories—including past flu, HIV‑1, MRSA, SARS‑CoV‑2 infections, anthrax vaccination, and even contact with organophosphate pesticides. By comparing the epigenetic landscapes of the four major immune cell groups, they identified thousands of differentially methylated regions (DMRs) that serve as molecular fingerprints of each cell type.
Inherited vs. Experience‑Driven Marks
Crucially, the researchers could separate DMRs that stem from genetic inheritance (gDMRs) from those driven by environmental encounters (eDMRs). Genetic marks tended to cluster near stable gene regions, especially within long‑lived T and B cells. In contrast, experience‑related marks were enriched in flexible regulatory zones that govern rapid immune responses.
These findings suggest a two‑layered system: your genome establishes a long‑term immune blueprint, while life experiences fine‑tune the system’s ability to react to new threats.
Implications for Predicting Disease and Personalizing Care
By providing a reference of how both inherited and acquired epigenetic cues shape immune cells, the atlas offers a springboard for precision medicine. As more patient data are added, clinicians may eventually predict how a person will respond to a future infection. For example, if a protective eDMR linked to milder COVID‑19 outcomes appears in a large cohort, doctors could screen new patients for that marker and, if absent, target the associated pathways to boost resilience.
"Our work lays the groundwork for precision‑prevention strategies against infectious diseases," one of the lead investigators said. "In the future, we might anticipate an individual's reaction to a virus before exposure, simply by reading their epigenetic signature."
Funding Acknowledgment
The study received support from the Defense Advanced Research Projects Agency via the U.S. Army Research Office, the National Institutes of Health, and the National Science Foundation.